SYMBOLLON CORP
8-K, 1999-10-13
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: PACIFIC CREST CAPITAL INC, SC 13G/A, 1999-10-13
Next: VERMONT TEDDY BEAR CO INC, SC 13D, 1999-10-13




                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549




                                    Form 8-K

                CURRENT REPORT Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934


                Date of Report (Date of earliest event reported):
                                October 13, 1999



                             SYMBOLLON CORPORATION
             (Exact name of Registrant as specified in its charter)


    Delaware                     0-22872                 36-3463683
- ----------------------------   -----------  ------------------------------------
(State or other jurisdiction   (Commission  (I.R.S. Employer Identification No.)
of incorporation)              File Number)



               37 Loring Drive, Framingham, Massachusetts 01702
               ---------------------------------------------------
               (Address of principal executive offices) (Zip Code)

               Registrant's telephone number, including area code:

                                 (508) 620-7676
                           -------------------------


                                 Not Applicable
                           -------------------------
         (Former name or former address, if changed since last report.)

<PAGE>


Item 5.  Other Events
         ------------
                  Following an oral hearing on August 12, 1999 before the Nasdaq
Listing   Qualifications  Panel  (the  "Panel")  in  connection  with  Symbollon
Corporation's  (the  "Company")  potential  delisting  from The Nasdaq  SmallCap
Market due to the Company's failure, as of June 30, 1999, to meet the applicable
listing requirement  stipulating  $2,000,000 in net tangible assets, the Company
received  a  letter   from   Nasdaq  on   September   23,   1999  (the   "Nasdaq
Correspondence").

                  The  Nasdaq  Correspondence   confirmed  that  the  Panel  has
determined to continue  listing the Company's  securities on The Nasdaq SmallCap
Market provided the Company  complies with the following  exception:  it makes a
public  filing  with the  Securities  and  Exchange  Commission  (the "SEC") and
Nasdaq, on or before October 15, 1999, evidencing a minimum of $2,700,000 in net
tangible  assets.  The filing must contain an August 31, 1999 balance sheet with
pro forma adjustments for any significant events or transactions occurring on or
before the filing  date.  In order to fully  comply with the terms of the Nasdaq
exception,  the  Company  must  be  able  to  demonstrate  compliance  with  all
requirements for continued  listing on The Nasdaq SmallCap Market.  However,  in
the event the Company  fails to meet any of the terms of the  Panel's  exception
and is delisted from The Nasdaq SmallCap Market, the Company's securities may be
eligible for listing in the OTC-Bulletin Board.

                  In accordance with the Nasdaq Correspondence,  the Company has
prepared a balance sheet as of August 31, 1999,  including pro forma adjustments
for any  significant  events or  transactions  occurring on or before the filing
date since August 31, 1999,  which is attached as Exhibit 99.1. The  information
presented on the attached  August 31, 1999 balance sheet has not been audited by
independent  accountants,  but includes all  adjustments  (consisting  of normal
recurring  accruals)  which are, in the opinion of  management,  necessary for a
fair  presentation  of the August 31, 1999 balance  sheet.  This  information is
provided solely for the purpose of complying with the requirements delineated by
Nasdaq pursuant to the exception recently granted to the Company.



<PAGE>



                  Certain information and footnote disclosures normally included
in  financial   statements   prepared  in  accordance  with  generally  accepted
accounting  principles  have been omitted.  The balance sheet  presented  herein
should be read in  conjunction  with the financial  statements and notes thereto
included  in the  Company's  Annual  Report on Form  10-KSB  for the year  ended
December  31, 1998 and the  quarterly  reports on Form  10-QSB for the  quarters
ended March 31, 1999 and June 30, 1999.

                  The  Company  believes  that it is in  compliance  on the date
hereof with all listing  requirements  for the  continued  listing on The Nasdaq
SmallCap Market.

                  Statements  herein  that  are  not  historical  facts  or that
express the beliefs and  expectations of management  regarding  future events or
performance  are forward  looking  statements  within the meaning of the Private
Securities  Litigation Reform Act of 1995. Those statements are subject to risks
and uncertainties that could cause actual results or events in future periods to
differ  materially  from  those  anticipated  or  forecasted.  Those  risks  and
uncertainties  are detailed from time to time in the Company's  filings with the
SEC.

Item 7.  Financial Statements, Pro Forma Financial Information and Exhibits
         ------------------------------------------------------------------
         (c)      Exhibits.
                  --------
         99.1     August 31,  1999  Condensed  Balance  Sheet of the  Company
                  including  pro forma  adjustments  for subsequent financing.


<PAGE>


                                    SIGNATURE



                  Pursuant to the requirements of the Securities Exchange Act of
1934,  the  Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

October 13, 1999                        SYMBOLLON CORPORATION


                                        By:   /s/ Paul C. Desjourdy
                                           ------------------------------
                                           Paul C. Desjourdy
                                           Executive Vice President and
                                           Chief Financial Officer


<PAGE>

                                INDEX TO EXHIBITS


Exhibit No.                  Description                               Page No.
- -----------                  -----------                               --------

  99.1               August 31, 1999  Condensed  Balance Sheet of the
                     Company  including  pro  forma  adjustments  for
                     subsequent financing.




                                                                    Exhibit 99.1
                                                                    ------------

                              SYMBOLLON CORPORATION
                          (a development stage company)

               CONDENSED BALANCE SHEET WITH PRO FORMA ADJUSTMENTS
                                   (unaudited)

                                     ASSETS
<TABLE>
<CAPTION>

                                                                                                                        Pro Forma
                                                                                                                          as of
                                                                                  August 31,         Pro Forma          August 31,
                                                                                    1999            Adjustments (a)       1999
                                                                                -------------      -------------      -------------
<S>                                                                             <C>                <C>                <C>
Current assets:
    Cash and cash equivalents...................................................   $2,160,671          $687,689          $2,848,360
    Restricted cash.............................................................      154,338                               154,338
    Accounts receivable.........................................................      201,534                               201,534
    Inventory...................................................................       83,995                                83,995
    Prepaid expenses............................................................       14,208                                14,208
                                                                                -------------      -------------      -------------
        Total current assets....................................................   $2,614,746          $687,689          $3,302,435
Equipment and leasehold improvements, net of
 accumulated depreciation and amortization......................................      103,033                               103,033
Other assets:
    Patent and trademark cost, net of accumulated amortization..................      218,355                               218,355
    Deposit.....................................................................        2,364                                 2,364
                                                                                -------------      -------------      -------------

        TOTAL...................................................................   $2,938,498          $687,689          $3,626,187
                                                                                =============      =============      =============

                                   LIABILITIES
Current liabilities:
    Accounts payable............................................................     $178,824                              $178,824
    Accrued expenses............................................................      304,037                               304,037
    Other current liabilities...................................................        1,450                                 1,450
                                                                                -------------      -------------      -------------
        Total current liabilities...............................................      484,311                               484,311

Redeemable common stock, Class A, par value $.001 per share,
 93,333 shares issued at August 31, 1999 and on a pro forma basis,
 respectively (aggregate involuntary liquidation value $175,000)................      175,000                               175,000


                              STOCKHOLDERS' EQUITY

Preferred stock, par value $.001 per share, 5,000,000 shares
 authorized, none issued........................................................
Common stock, Class A, par value $.001 per share,
 18,750,000 shares authorized, 3,806,048 and 4,221,783 shares issued at
 August 31, 1999 and on a pro forma basis, respectively.........................        3,495               416               3,911
Convertible Common stock, Class B, par value $.001 per share,
 1,250,000 shares authorized, 15,738 shares issued..............................           16                                    16
Additional paid-in capital......................................................    8,244,174           687,273           8,931,447
Deficit accumulated during the development stage................................   (5,968,498)                           (5,968,498)
                                                                                --------------     -------------      -------------
    Total stockholders' equity..................................................    2,279,187           687,689           2,966,876

                                                                                --------------     -------------      -------------
    TOTAL.......................................................................   $2,938,498          $687,689          $3,626,187
                                                                                ==============     =============      =============

(a)  Adjustments give effect to the sales proceeds (net of placement agent's commissions) from the sale of 415,735 units
     (the "Units"), each Unit consisting of one share of Class A Common Stock and one redeemable warrant, which occurred from
      September 1, 1999 to the filing date hereof.

</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission